RA
RDY icon

Royce & Associates’s Dr. Reddy's Laboratories RDY Stock Holding History

Royce & Associates’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-5,000
Closed -$38K – 1469
2013
Q3 		$38K Buy
+5,000
New +$36.4K ﹤0.01% 1413

Other funds holding RDY

CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Royce & Associates's RDY Position: Q4 2013 in Review

Royce & Associates sold out of Dr. Reddy's Laboratories (RDY) in Q4 2013, closing a stake of 5,000 shares — an estimated $38K sold.

Royce & Associates first reported a position in RDY in Q3 2013 and held it in 1 quarter. The position peaked at $38K in Q3 2013. 149 funds tracked by Wall St. Rank hold RDY as of Q4 2013.

  • Royce & Associates reported no remaining Dr. Reddy's Laboratories position as of Q4 2013 after selling out during the quarter.
  • Royce & Associates sold 5,000 Dr. Reddy's Laboratories shares in Q4 2013, an estimated $38K.
  • Royce & Associates first reported a position in Dr. Reddy's Laboratories in Q3 2013 and held it in 1 quarter.
  • Royce & Associates's Dr. Reddy's Laboratories position peaked at $38K in Q3 2013.
  • 149 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2013.

Based on Royce & Associates's 13F filing for Q4 2013, filed 10 Feb 2014.